Company
Stradefy Biosciences
Pioneering next-generation Bioadhesive Drug Carriers (BDCs)
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Stradefy Biosciences is pioneering next-generation bioadhesive drug carriers (BDCs), rationally engineered for cellular bioadhesion, uptake and therapeutic payload release, at levels well beyond seen with antibody drug conjugates (ADCs). Lead candidates, initially targeting unmet needs in the oncology and immunology areas, have demonstrated in vivo proof of efficacy and are advancing to the IND stage.
Products
- Web
- Bioadhesive Drug Carriers (BDCs)
Loading relationship preview